Technologies

time icon Feb. 1, 2012

An Improved Screening Assay for Thrombin Receptor Antagonists

Technology description

Summary

An Assay for Thrombis Receptor Activation and Its Application to the Identification of thrombin Receptor Antagonists

Description

Thrombin and thrombin receptors are important in the development of the platelet plug and fibrin clot that are normally formed during vascular injury. However, they are also involved in events leading to strokes, myocardial infarcts, and other cardiovascular diseases. Accordingly, there is considerable effort being expended to find inhibitors of these compounds. The current screening methods require fresh human platelets and are therefore limited by reagent toxicity to platelets when used in the tests. These assays also do not appear to be receptor-specific. There has not been an available assay for screening large compound libraries for potential antagonists of thrombin receptor activity. Researchers at the University of Pennsylvania have developed an antagonist-screening assay that is specific for the thrombin receptor. This method also allows researchers to perform the assay in micro-titer plates, provides a high signal to noise ratio and relative insensitivity to the reagents used in traditional assays. Further, the assay uses cells easily grown in culture, rather than freshly collected human platelets.

由于技术保密工作限制,技术信息无法完全展现,请通过邮箱或短信联系我们,获取更多技术资料。

More information

Categories
  • Diagnosis and treatment
  • Hematology
  • Vascular surgery
Keywords:

cells easily grown

thrombis receptor activation

thrombin receptor activity

下载 PDF 文档


感兴趣

Contact us

知繁业茂-yintrust logo知繁业茂-Branchly Innovation logo 知繁业茂-autmasia logo迈科技 logo